Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model
A therapeutic approach to improve treatment outcome of ovarian cancer (OC) in patients is urgently needed. Myxoma virus (MYXV) is a candidate oncolytic virus that infects to eliminate OC cells. We found that in vitro MYXV treatment enhances cisplatin or gemcitabine treatment by allowing lower doses...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2017-09-01
|
| Series: | Molecular Therapy: Oncolytics |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2372770517300311 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|